139 related articles for article (PubMed ID: 3598157)
21. A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients.
Alexander GJ; Fagan EA; Guarner P; Rolando N; Brahm J; Eddleston AL; Williams R
J Hepatol; 1986; 3 Suppl 2():S183-8. PubMed ID: 3298406
[TBL] [Abstract][Full Text] [Related]
22. A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules.
Carreño V; Porres JC; Mora I; Gutiez J; Quiroga JA; Ramón y Cajal S; Oliva H; Compernolle C; Bartolomé J
Antiviral Res; 1987 Oct; 8(3):125-37. PubMed ID: 3501274
[TBL] [Abstract][Full Text] [Related]
23. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors.
Brook MG; Karayiannis P; Thomas HC
Hepatology; 1989 Nov; 10(5):761-3. PubMed ID: 2680866
[TBL] [Abstract][Full Text] [Related]
24. Treatment of chronic hepatitis B with recombinant leukocyte interferon and cyanidanol.
Kanai K; Morioka S; Nakajima T; Ishii H; Tamakoshi K; Matsuda H; Matsumoto M; Mizushima N; Takehira Y
Gastroenterol Jpn; 1988 Feb; 23(1):44-8. PubMed ID: 3350278
[TBL] [Abstract][Full Text] [Related]
25. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
Lai CL; Lok AS; Lin HJ; Wu PC; Yeoh EK; Yeung CY
Lancet; 1987 Oct; 2(8564):877-80. PubMed ID: 2889081
[TBL] [Abstract][Full Text] [Related]
26. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
Eisenburg J; Caselmann W; Eder M; Pape GR
Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
[No Abstract] [Full Text] [Related]
27. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon.
Lin CY
Kidney Int; 1995 Jan; 47(1):225-30. PubMed ID: 7731150
[TBL] [Abstract][Full Text] [Related]
28. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
Stancek D; Hajnická V; Blaskovicová H; Sudová J; Laktis K; Janota S; Jezek P
Acta Virol; 1990 Sep; 34(5):457-66. PubMed ID: 1981456
[TBL] [Abstract][Full Text] [Related]
29. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
McDonald JA; Caruso L; Karayiannis P; Scully LJ; Harris JR; Forster GE; Thomas HC
Hepatology; 1987; 7(4):719-23. PubMed ID: 3038722
[TBL] [Abstract][Full Text] [Related]
30. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
Pastore G; Santantonio T; Monno L; Milella M; Luchena N; Angarano G
Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
[TBL] [Abstract][Full Text] [Related]
31. Pilot study of recombinant human alpha-interferon for chronic type B hepatitis.
Dooley JS; Davis GL; Peters M; Waggoner JG; Goodman Z; Hoofnagle JH
Gastroenterology; 1986 Jan; 90(1):150-7. PubMed ID: 3940241
[TBL] [Abstract][Full Text] [Related]
32. [Chronic infection due to hepatitis B virus in patients less than 16 years of age: therapeutic approach by means of interferon alfa-2b].
Vetencourt R; Oropeza F; de Armas J; Cordero I; de Silva M; Machado I; Vetencourt M; Mendoza J
G E N; 1990; 44(4):353-60. PubMed ID: 2152277
[TBL] [Abstract][Full Text] [Related]
33. Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
Anderson MG; Harrison TJ; Alexander GJ; Zuckerman AJ; Murray-Lyon IM
J Hepatol; 1986; 3 Suppl 2():S225-7. PubMed ID: 3298409
[TBL] [Abstract][Full Text] [Related]
34. Recombinant alpha 2-interferon treatment in children with chronic hepatitis B.
La Banda F; Ruiz Moreno M; Carreño V; Bartolome J; Gutiez J; Ramon y Cajal S; Moreno A; Mora I; Carlos Porres J
Lancet; 1988 Jan; 1(8579):250. PubMed ID: 2893078
[No Abstract] [Full Text] [Related]
35. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
Ruiz Moreno M; Jimenez J; Porres JC; Bartolomé J; Moreno A; Carreño V
Digestion; 1990; 45(1):26-33. PubMed ID: 2187723
[TBL] [Abstract][Full Text] [Related]
36. Alpha interferon therapy in children with chronic active hepatitis B and delta virus infection.
Kay MH; Wyllie R; Deimler C; Caulfield M; Steffen R; Baetz-Greenwalt B
J Pediatr; 1993 Dec; 123(6):1001-4. PubMed ID: 8229507
[TBL] [Abstract][Full Text] [Related]
37. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
38. The value of quantitative measurement of HBeAg and HBsAg before interferon-alpha treatment of chronic hepatitis B in children.
Burczynska B; Madalinski K; Pawlowska J; Woynarowski M; Socha J; Gerlich WH; Willems WR; Wozniewicz B; Stachowski J
J Hepatol; 1994 Dec; 21(6):1097-102. PubMed ID: 7699234
[TBL] [Abstract][Full Text] [Related]
39. Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis.
Schalm SW; Heytink RA; Van Buuren HR; De Man RA
J Hepatol; 1986; 3 Suppl 2():S189-92. PubMed ID: 3598156
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of patients with chronic hepatitis B after interferon treatment.
Teuber G; Dienes HP; Meyer Zum Büschenfelde KH; Gerken G
Z Gastroenterol; 1996 Apr; 34(4):230-6. PubMed ID: 8686350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
